Last reviewed · How we verify
Intraarticular betamethasone
At a glance
| Generic name | Intraarticular betamethasone |
|---|---|
| Sponsor | Hvidovre University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Capsular Distension Versus Corticosteroid Injection in Adhesive Capsulitis (NA)
- Ultrasound-Guided Intra-Articular vs Gluteal Intramuscular Corticosteroid Injection for Frozen Shoulder (PHASE4)
- Effect of Reparel Knee Sleeve With Knee Injection (NA)
- Safety and Efficacy of Platelet-Rich Plasma Combined With Compound Betamethasone in Arthroscopic Surgery for Rotator Cuff Injury With Shoulder Adhesion: A Prospective, Multicenter, Randomized Controlled Trial (NA)
- EFFECT OF INTRAARTICULAR TRIAMCINOLONE HEXACETONIDE AND BETAMETHASONE ON INTRAOCULAR PRESSURE (PHASE4)
- Suprascapular Nerve Block in the Management of Patients Diagnosed With Adhesive Capsulitis (NA)
- Comparative Effectiveness of Particulate Versus Nonparticulate Steroid Injections for Musculoskeletal Conditions (PHASE4)
- Ultrasound-guided Injection of Glucocorticoid Into Infrapatellar Fat Pad in Patients With Knee Osteoarthritis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intraarticular betamethasone CI brief — competitive landscape report
- Intraarticular betamethasone updates RSS · CI watch RSS
- Hvidovre University Hospital portfolio CI